title: Physician perceptions and practices in management of diabetes in India: Results from the IMPROVE Control program.
abstract: BACKGROUND
  The impact of IMPROVE Control Training program was evaluated by a non-interventional study and validated by a physician perception questionnaire. From a survey on 1086 physicians providing diabetes care in India, we report their practices and perceptions about diabetes care and insulin therapy.
  
  
  METHODS
  The responses were collected using a questionnaire validated by the IMPROVE Control Steering Committee.
  
  
  RESULTS
  Majority [558 (51.4%)] of the physicians accepted the ADA defined HbA1c target of <7% as the standard for good glycemic control in their practice. However, 541 (49.8%) of the physicians agreed that only 20-40% of their patients were able to achieve this target. For patients who do not achieve the glycemic control with oral anti-diabetic drugs (OADs) within 6 months of initiation of therapy, initiation of an optimal insulin regimen was the preferred choice for 492 (45.3%) of the participating physicians. Premixed insulin was preferred for initiating insulin therapy in patients with type 2 diabetes, by 676 (62.2%) of the participants [as compared to basal by 375 (34.5%) participants]. Once daily premixed insulin, intensified to twice daily was preferred as most optimal insulin regimen for initiation and subsequent intensification of insulin therapy [487 (44.8%) participants]. Most of the participants preferred adopting a multi-targeted approach for treating diabetes, hypertension, and dyslipidemia.
  
  
  CONCLUSIONS
  Physicians prefer treatment goals similar to those recommended in the current guidelines of the American Diabetes Association for managing their patients with diabetes. Premixed insulin is preferred for initiation and intensification of insulin therapy.
authors.affiliation: Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi, India.
authors.forename: A G
authors.initials: AG
authors.lastname: Unnikrishnan
authors.forename: S K
authors.initials: SK
authors.lastname: Wangnoo
authors.forename: S R
authors.initials: SR
authors.lastname: Joshi
authors.forename: S
authors.initials: S
authors.lastname: Banerjee
authors.forename: A
authors.initials: A
authors.lastname: Kumar
authors.forename: S
authors.initials: S
authors.lastname: Kalra
authors.forename: R
authors.initials: R
authors.lastname: Channabasavaiah
authors.forename: R
authors.initials: R
authors.lastname: Shetty
keywords: IMPROVE; oral anti diabetic drugs; premixed insulin; treatment goals
references.citation: N Engl J Med. 2008 Oct 9;359(15):1577-89
references.pmid: 18784090
references.citation: Prim Care Diabetes. 2010 Dec;4(4):203-7
references.pmid: 20719586
references.citation: Diabetologia. 2012 Jun;55(6):1577-96
references.pmid: 22526604